Why the study?
How do catecholamines and cyclic AMP affect lipolysis in human subcutaneous and omental adipose tissue?
How do catecholamines and cyclic AMP affect lipolysis in human subcutaneous and omental adipose tissue?
Catecholamine-induced lipolysis in human adipose tissue is mediated by beta-adrenergic receptors, inhibited by alpha receptors, and is lower in subcutaneous tissue likely due to lower cyclic AMP formation.
No takes yet. Share an insight, caveat, or question.
Animal findings on depot-specific lipolysis require human confirmation; leaves open relevance to metabolic disease.
Suad Efendić (1970) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: